Zohra Dhouafli, Manuela Leri, Monica Bucciantini, Massimo Stefani, Hamza Gadhoumi, Borhane Mahjoub, Hichem Ben Jannet, Jérôme Guillard, Riadh Ksouri, Moufida Saidani Tounsi, Claudio Soto, El Akrem Hayouni
Journal: BioFactors (Oxford, England) 2018;44(3):272-280
PMID: 29582494
Presently, misfolding and aggregation of amyloid-β (Aβ ) are considered early events in Alzheimer's disease (AD) pathogenesis. The use of natural products to inhibit the aggregation process and to protect cells from cytotoxicity of early aggregate grown at the onset of the aggregation path is one of the promising strategies against AD. Recently, we have purified a new powerful antioxidant and inhibitor of Aβ aggregation from the leaves of Lawsonia inermis. The new compound was identified as a new Lawsoniaside; 1,2,4-trihydroxynaphthalene-2-O-β-D-glucopyranoside (THNG). Herein, we show that THNG interferes with Aβ aggregation, inhibits its conformational change to a β-sheet-rich structure, decreases its polymerization into large fibrillar species, reduces oxidative stress, and aggregate cytotoxicity. These results indicate that THNG has great potential as a neuroprotective and therapeutic agent against AD. © 2018 BioFactors, 44(3):272-280, 2018.
© 2018 International Union of Biochemistry and Molecular Biology.
Other Literature Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.